as well as their corporate headquarters. Germany-based Boehringer Ingelheim scored highly for wellbeing – particularly for its commitment to prioritising mental health for employees – and ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...

By Noah Weiland and Rebecca Robbins Hikma said it had reduced the cash portion of the offer as Boehringer Ingelheim’s generic drugs business in the U.S. had lower-than-expected sales.

BERLIN, Oct. 15, 2024 /PRNewswire/ -- Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to ...

Learn more at https://www.boehringer-ingelheim.com. This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business.

Boehringer Ingelheim and Circle Pharma have entered a new research partnership and licence agreement to develop a new ...

Learn more at https://www.boehringer-ingelheim.com. This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business.

Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment ...

Find out how this could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations.

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...